Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Genfit Launches IPO To Expand US Presence Ahead Of Phase III NASH Results

Mar 28 2019

• By Mandy Jackson

Finance Watch

Related Content

Curis Set For Transformative Year With <em>Erivedge</em> Skin Cancer Approval

Feb 06 2012

Syndax Sees Subgroup Efficacy For Entinostat Plus Keytruda In NSCLC

May 18 2018

Finance Watch: Investment In Novel Antibacterials Gets A New Boost With Qpex Launch

Oct 23 2018

IPO Update: Returns Sag As Seven More Biopharmas Go Public In September

Oct 02 2018

Gilead Hit With Another NASH Setback As Selonsertib Fails In First Phase III

Feb 11 2019

Intercept Retakes The Lead In NASH

Feb 19 2019

Heplisav-B Approval Has Dynavax Going It Alone On US Launch In Early 2018

Nov 13 2017

IPO Update: Seven In January As Big Returns, Solid's Slip-Up Contribute To Bubble Concerns

Feb 02 2018

Finance Watch: Investors Can't Get Enough Of NASH, Including Start-Ups With Novel Drugs

Nov 02 2018

Finance Watch: Investors Go Nuts For NASH As Madrigal Raises $300m, Galmed Skyrockets

Jun 15 2018

IPO Update: Returns Run Red For Most Biopharma Firms That Went Public In The US Last Year

Jan 04 2019

MyoKardia Frames End Of Sanofi Partnership As A Bet On Itself

Jan 02 2019

Pain Therapeutics Appeals Remoxy CRL In Likely Last Ditch Effort To Save Abuse-Deterrent Opioid

Nov 20 2018

Genfit May Be Gaining An Edge In NASH Race

Oct 26 2017

AbbVie’s Business Development, Cancer Plans Not Put Off By Stemcentrx Disappointments

Jan 10 2019

Finance Watch: VC Mega-Deals Launch Biopharma Firms With New Takes On CV, Genetic Diseases

Mar 05 2019

Aldeyra One Step Closer To Joint Treatment For Allergic Conjunctivitis, Dry Eye Disease

Mar 26 2019

Dermira’s Lebrikizumab Data Set Up Atopic Dermatitis Showdown With Dupixent

Mar 18 2019

Finance Watch: Panic Over FDA Commissioner's Resignation Was Short-Lived, Though IPOs Still Languish

Mar 18 2019

Related Companies

Genfit SA

Gilead Sciences, Inc.

NGM Biopharmaceuticals, Inc.

Precision BioSciences, Inc.

HOOKIPA Pharma Inc.

Turning Point Therapeutics Inc.

MyoKardia, Inc.

Dermira Inc.

Tricida, Inc.

Curis, Inc.

Genentech, Inc.

Dynavax Technologies Corporation

Aldeyra Therapeutics, Inc.

resTORbio, Inc.

Syndax Pharmaceuticals, Inc.

AbbVie Inc.

Cassava Sciences, Inc.

ProQR Therapeutics N.V.

Additional Topics

Financing Business Strategies Innovation StartUps and SMEs Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window